drugset / Trial / NCT00674765

Seroquel for Frequent, Heavy Drinkers

NCT00674765 ↗

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to examine the effects of quetiapine in reducing percent heavy drinking days and increasing percent abstinent days in alcohol dependent patients who are frequent heavy drinkers.

Timeline

Start
2008-01
Primary completion
2013-01
Completion
2014-01

Outcome

Missed primary endpoint

registry Seroquel (Quetiapine) vs Placebo Sugar Pill; p = .388; t-test, 2 sided NCT00674765 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Quetiapine Small molecule 400 mg —

Indications